163 related articles for article (PubMed ID: 32583599)
1. Impact of primary aldosteronism on renal function in patients with type 2 diabetes.
Katsuragawa S; Tsurutani Y; Takiguchi T; Saito J; Nishikawa T
J Diabetes Investig; 2021 Feb; 12(2):217-225. PubMed ID: 32583599
[TBL] [Abstract][Full Text] [Related]
2. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
[TBL] [Abstract][Full Text] [Related]
3. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
[TBL] [Abstract][Full Text] [Related]
4. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.
Kobayashi H; Abe M; Nakamura Y; Takahashi K; Fujita M; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Wada N; Ichijo T; Katabami T; Ogawa Y; Kawashima J; Yoshimoto T; Sone M; Inagaki N; Watanabe M; Kamemura K; Matsuda Y; Izawa S; Tanabe M; Tanabe A; Suzuki T; Naruse M;
Hypertension; 2019 Sep; 74(3):630-638. PubMed ID: 31327258
[TBL] [Abstract][Full Text] [Related]
5. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.
Tanase-Nakao K; Naruse M; Nanba K; Tsuiki M; Tagami T; Usui T; Okuno H; Shimatsu A; Hashimoto S; Katabami T; Ogo A; Okumura A; Umakoshi H; Suzuki T
Clin Endocrinol (Oxf); 2014 Nov; 81(5):665-70. PubMed ID: 24821606
[TBL] [Abstract][Full Text] [Related]
8. Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.
Utsumi T; Kawamura K; Imamoto T; Nagano H; Tanaka T; Kamiya N; Nihei N; Naya Y; Suzuki H; Ichikawa T
Int J Urol; 2013 Jul; 20(7):685-91. PubMed ID: 23190329
[TBL] [Abstract][Full Text] [Related]
9. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
Kim IY; Park IS; Kim MJ; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH; Chung HC
Int Urol Nephrol; 2018 Oct; 50(10):1887-1895. PubMed ID: 29779118
[TBL] [Abstract][Full Text] [Related]
10. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.
Utsumi T; Kamiya N; Kaga M; Endo T; Yano M; Kamijima S; Kawamura K; Imamoto T; Ichikawa T; Suzuki H
World J Urol; 2017 Oct; 35(10):1577-1583. PubMed ID: 28401356
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism.
Saiki A; Otsuki M; Tamada D; Kitamura T; Shimomura I; Kurihara I; Ichijo T; Takeda Y; Katabami T; Tsuiki M; Wada N; Yanase T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Yoshimoto T; Okamoto R; Takahashi K; Kobayashi H; Tamura K; Kamemura K; Yamamoto K; Izawa S; Kakutani M; Yamada M; Tanabe A; Naruse M
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32275055
[TBL] [Abstract][Full Text] [Related]
12. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
13. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
[TBL] [Abstract][Full Text] [Related]
14. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism.
Onohara T; Takagi T; Yoshida K; Iizuka J; Okumi M; Kondo T; Ishida H; Tanabe K
Int J Urol; 2019 Feb; 26(2):229-233. PubMed ID: 30384394
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.
Kim DH; Kwon HJ; Ji SA; Jang HR; Jung SH; Kim JH; Kim JH; Lee JE; Huh W; Kim YG; Kim DJ; Oh HY
Medicine (Baltimore); 2016 Jul; 95(27):e3930. PubMed ID: 27399066
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes.
Miyoshi H; Kameda H; Yamashita K; Nakamura A; Kurihara Y
J Diabetes Investig; 2019 Nov; 10(6):1510-1517. PubMed ID: 31026373
[TBL] [Abstract][Full Text] [Related]
17. Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: A multiethnic study.
Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang KKL; Tang WE; Kwan PY; Tavintharan S; Sum CF; Lim SC
Diab Vasc Dis Res; 2018 Sep; 15(5):417-423. PubMed ID: 29807475
[TBL] [Abstract][Full Text] [Related]
18. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
Wada N; Shibayama Y; Umakoshi H; Ichijo T; Fujii Y; Kamemura K; Kai T; Sakamoto R; Ogo A; Matsuda Y; Fukuoka T; Tsuiki M; Suzuki T; Naruse M
J Hum Hypertens; 2017 Oct; 31(10):627-632. PubMed ID: 28540931
[TBL] [Abstract][Full Text] [Related]
19. Effects of Treating Primary Aldosteronism on Renal Function.
Kramers BJ; Kramers C; Lenders JW; Deinum J
J Clin Hypertens (Greenwich); 2017 Mar; 19(3):290-295. PubMed ID: 27659389
[TBL] [Abstract][Full Text] [Related]
20. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]